The Epic Transformation of BioNTech: From Vaccine Titan to Oncology Pioneer
BioNTech is transitioning from COVID-19 vaccine production to developing mRNA therapies for cancer, specifically targeting bladder and colon cancer, with potential breakthroughs expected by 2026. Despite financial challenges, including a…